Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. The Company's subsidiary, Harvest Medicine provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Post by subaru1ion Apr 07, 2023 2:58pm
210 Views
Post# 35384814

RE: LABS Roth conference 2023

RE: LABS Roth conference 2023Thank you for that post.  I liked the way it was emphasized that LABS is not a "pot stock" but rather a pharmaceutical company developing a new class of pharmaceutical API's.   

Imho, I believe we are entering a period of the "perfect storm" for our LABS holdings because it is now quite evident the U.S. is heading into a recessionary period for 2023.  How deep that recession will be lingers on the question of U.S. foreign policy as self proclaimed rulers of the world.   A bit more on that later on.  Getting back to LABS, finding growth opportunities becomes very scarce during a recession with the majority of companies feeling the economic burden of much slower and even negative growth.  The segment that LABS is in has an important element.  In general there is no substitue product for human well being/health like substituting red meat for a less costly alternative such as chicken.   Any growth demonstrated by LABS within a recessionary period will be amplified within the markets.  

Be thankful LABS is not listed on the NASDAQ....how deep will the U.S. recession be?  We already witnessed the political organization, now the 2 largest members aligned with China, called OPEC+ load a small artillery round in it's cannon and fired off a cut in oil production.  Thinly veiled imho to reduce oil inventories but like any other item, it can be weaponized unless some of you never heard about the 1973 oil embargo and oil quadrupling in price due to the Israel-Arab war with the U.S. backing Israel.   Today, at this very moment, we are seeing the far right wing government of Israel taking actions actions against Palestine, Syria, and Lebanon while the U.S. is staying quiet.  

Oil at over $150 per barrel? Gold at $3000?  Nuclear war is not a very efficient method but another oil embargo repeat, as history does, would destabilize the U.S. economy as having the highest per capita oil consumption and relying on imports not to mention being a debtor nation compared to China's central bank having currency reserves of over 300% to their GDP.   

OPEC+ (Russia and Saudi Arabia being the 2 elephants in the room) merely needs to, as the U.S. has been doing unfairly towards China, is "sanction" oil into the commodities market while still supplying China through off market deals.   

Now, consider this carefully, the shear stupidity of the U.S.   They are trying to ramp up electric vehicle production as fast as possible but there's one big problem.   The power grid of that country is not capable of handling all Americans plugging in their electric cars, especially in places like California or New York where a heat wave suddenly creates critical conditions on those grids.   

So be thankful LABS is not listed on the NASDAQ because the Canadian economy, albeit exposed to the North Amercian auto industry (ones to suffer first during a recession), still retains a commodity/resource based economy (grains, live stock, minerals, lumber, oil, natural gas).   

You astute investors out there need to broaden your focus to the geopolitical events as well so that you minimize your risk exposure when and if OPEC+ and China decide to bring the U.S. economy down extremely hard. Japan with over 200% debt to GDP would economically implode.   

A note to the Pentagon: You guys are really stupid because 25 years ago you should have commmercialized spintronic based solid state devices to reduce power consumption and grid loads instead of hoarding that technology for the military.   I'm just sitting back here today and relaxing while you guys cut your own throats.  

New defacto global currency? Won't be the U.S. dollar anymore.  In the interim, people need food and energy, commodities and oil futures are always a long term safe haven.  

Thanks again for posting the link to the Roth conference.   
<< Previous
Bullboard Posts
Next >>